Human fibulin-3 protein variant expresses anti-cancer effects in the malignant glioma extracellular compartment in intracranial xenograft models
Authors:
Open Access
- 9 November 2017
- journal article
- Published by Impact Journals, LLC in Oncotarget
- Vol. 8 (63) , 106311-106323
Abstract
Background: Decades of cytotoxic and more recently immunotherapy treatments for malignant glioma have had limited success due to dynamic intra-tumoral heterogeneity. The dynamic interplay of cancer cell subpopulations has been found to be under the control of proteins in the cancer microenvironment. EGF-containing fibulin-like extracellular matrix protein (EFEMP1) (also fibulin-3) has the multiple functions of suppressing cancer growth and angiogenesis, while promoting cancer cell invasion. EFEMP1-derived tumor suppressor protein (ETSP) retains EFEMP1’s anti-growth and anti-angiogenic functions while actually inhibiting cancer cell invasion. Methods: In this study, we examined the therapeutic effect on glioblastoma multiforme (GBM) of anin vitro synthesized protein, ZR30, which is based on the sequence of ETSP, excluding the signaling peptide.Results: ZR30 showed the same effects as ETSP in blocking EGFR/NOTCH/AKT signaling pathways, when applied to cultures of multiple GBM cell lines and primary cultures. ZR30’s inhibition of MMP2 activation was shown not only for GBM cells, but also for other types of cancer cells having overexpression of MMP2. A significant improvement in survival of mice with orthotopic human GBM xenografts was observed after a single, intra-tumoral injection of ZR30. Using a model mimicking the intra-tumoral heterogeneity of GBMwith cell subpopulations carrying different invasive and proliferative phenotypes, we demonstrated an equal and simultaneous tumor suppressive effect of ZR30 on both tumor cell subpopulations, with suppression ofFOXM1and activation of SEMA3B expressions in the xenografts. Conclusion: Overall, the data support a complementary pleiotrophic therapeutic effect of ZR30 acting in the extracellular compartment of GBM.Keywords
This publication has 20 references indexed in Scilit:
- Tumor-Specific Chromosome Mis-Segregation Controls Cancer Plasticity by Maintaining Tumor HeterogeneityPLOS ONE, 2013
- Detection of 1p19q Deletion by Real-Time Comparative Quantitative PCRBiomarker Insights, 2012
- EFEMP1 suppresses malignant glioma growth and exerts its action within the tumor extracellular compartmentMolecular Cancer, 2011
- Grade-Specific Expression of Insulin-like Growth Factor–Binding Proteins-2, -3, and -5 in Astrocytomas: IGFBP-3 Emerges as a Strong Predictor of Survival in Patients with Newly Diagnosed GlioblastomaCancer Epidemiology, Biomarkers & Prevention, 2010
- Notch Promotes Radioresistance of Glioma Stem CellsStem Cells, 2009
- NOTCH Pathway Blockade Depletes CD133-Positive Glioblastoma Cells and Inhibits Growth of Tumor Neurospheres and XenograftsStem Cells, 2009
- Semaphorin 3B Inhibits the Phosphatidylinositol 3-Kinase/Akt Pathway through Neuropilin-1 in Lung and Breast Cancer CellsCancer Research, 2008
- Semaphorin, neuropilin and VEGF expression in glial tumours: SEMA3G, a prognostic marker?British Journal of Cancer, 2008
- PAX6 Suppresses the Invasiveness of Glioblastoma Cells and the Expression of the Matrix Metalloproteinase-2 GeneCancer Research, 2006
- Allele loss and epigenetic inactivation of 3p21.3 in malignant liver tumorsInternational Journal of Cancer, 2005